Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1985 2
1991 1
1992 2
1998 1
2000 3
2001 2
2003 4
2004 5
2005 1
2006 1
2007 4
2008 4
2009 4
2010 4
2011 1
2012 1
2013 1
2014 2
2015 6
2016 5
2017 3
2018 1
2019 4
2020 4
2021 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Olmsted syndrome 2"
Page 1
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T; COVE Study Group. Baden LR, et al. N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30. N Engl J Med. 2021. PMID: 33378609 Free PMC article. Clinical Trial.
The mRNA-1273 vaccine is a lipid nanoparticle-encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Covid-19. METHODS: This ph …
The mRNA-1273 vaccine is a lipid nanoparticle-encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protei …
Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, Jordan L, Lanzkron SM, Lottenberg R, Savage WJ, Tanabe PJ, Ware RE, Murad MH, Goldsmith JC, Ortiz E, Fulwood R, Horton A, John-Sowah J. Yawn BP, et al. JAMA. 2014 Sep 10;312(10):1033-48. doi: 10.1001/jama.2014.10517. JAMA. 2014. PMID: 25203083 Review.
EVIDENCE REVIEW: Databases of MEDLINE (including in-process and other nonindexed citations), EMBASE, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, CINAHL, TOXLINE, and Scopus were searched using prespecified search terms and keywords to …
EVIDENCE REVIEW: Databases of MEDLINE (including in-process and other nonindexed citations), EMBASE, Cochrane Database of Systematic Reviews …
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ, Campbell TB, Clark J, Jackson LA, Fichtenbaum CJ, Zervos M, Rankin B, Eder F, Feldman G, Kennelly C, Han-Conrad L, Levin M, Neuzil KM, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Polakowski L, Mascola JR, Ledgerwood JE, Graham BS, August A, Clouting H, Deng W, Han S, Leav B, Manzo D, Pajon R, Schödel F, Tomassini JE, Zhou H, Miller J; COVE Study Group. El Sahly HM, et al. N Engl J Med. 2021 Nov 4;385(19):1774-1785. doi: 10.1056/NEJMoa2113017. Epub 2021 Sep 22. N Engl J Med. 2021. PMID: 34551225 Free PMC article. Clinical Trial.
BACKGROUND: At interim analysis in a phase 3, observer-blinded, placebo-controlled clinical trial, the mRNA-1273 vaccine showed 94.1% efficacy in preventing coronavirus disease 2019 (Covid-19). ...The primary end point was prevention of Covid-19 illness with onset a …
BACKGROUND: At interim analysis in a phase 3, observer-blinded, placebo-controlled clinical trial, the mRNA-1273 vaccine showe …
Treatment Strategies for Generator Pocket Pain.
Bao J, Khazen O, Olmsted ZT, Gechtman G, Shao MM, DiMarzio M, Topp G, Sukul VV, Staudt MD, Pilitsis JG. Bao J, et al. Pain Med. 2021 Jun 4;22(6):1305-1311. doi: 10.1093/pm/pnab007. Pain Med. 2021. PMID: 33502508 Free PMC article.
Females were overrepresented in pocket pain cohort (76.7%) when compared with the total SCS cohort (59.0%) (X2 = 5.93, P = 0.015). Diagnosis included failed back surgery syndrome (51.2%), complex regional pain syndrome (23.3%), and chronic neuropathic pain (2 …
Females were overrepresented in pocket pain cohort (76.7%) when compared with the total SCS cohort (59.0%) (X2 = 5.93, P = 0.015). Diagnosis …
Epidemiology of Guillain-Barre syndrome.
Schoenberg BS. Schoenberg BS. Adv Neurol. 1978;19:249-60. Adv Neurol. 1978. PMID: 369322 Review.
The only measures of morbidity for Guillain-Barre syndrome in well-defined populations in the continental United States come from Olmsted County, Minnesota, and San Joaquin County, California. ...The rarity of the condition and the variations in its clinical …
The only measures of morbidity for Guillain-Barre syndrome in well-defined populations in the continental United States come from …
Olmsted syndrome.
Ali ME, Sikdar AU, Akhtar N, Islam ZM. Ali ME, et al. Mymensingh Med J. 2007 Jan;16(1):100-3. doi: 10.3329/mmj.v16i1.262. Mymensingh Med J. 2007. PMID: 17344790
Olmsted syndrome is a rare disorder characterized by symmetrical sharply marginated mutilating keratoderma of palms & soles & hyperkeratotic plaques around the body orifices, onychodystrophy, ainhum & amputation of digital phalanges, flextion deformities …
Olmsted syndrome is a rare disorder characterized by symmetrical sharply marginated mutilating keratoderma of palms & sole …
Exposure to anesthesia is not associated with development of α-synucleinopathies: A nested case-control study.
Laporta ML, Kruthiventi SC, Stang CD, Camerucci E, Martin DP, Weingarten TN, Hanson AC, Schroeder DR, Warner DO, Savica R, Sprung J. Laporta ML, et al. Parkinsonism Relat Disord. 2021 Jul;88:76-81. doi: 10.1016/j.parkreldis.2021.06.001. Epub 2021 Jun 8. Parkinsonism Relat Disord. 2021. PMID: 34147949 Free PMC article.
We explored the role of general anesthesia in the development of Parkinson disease (PD) and other alpha-synucleinopathies. METHODS: All alpha-synucleinopathy cases in Olmsted County, Minnesota, from January 1991, to December 2010, were identified from diagnostic codes, and …
We explored the role of general anesthesia in the development of Parkinson disease (PD) and other alpha-synucleinopathies. METHODS: All alph …
PAR2 Mediates Itch via TRPV3 Signaling in Keratinocytes.
Zhao J, Munanairi A, Liu XY, Zhang J, Hu L, Hu M, Bu D, Liu L, Xie Z, Kim BS, Yang Y, Chen ZF. Zhao J, et al. J Invest Dermatol. 2020 Aug;140(8):1524-1532. doi: 10.1016/j.jid.2020.01.012. Epub 2020 Jan 29. J Invest Dermatol. 2020. PMID: 32004565 Free PMC article.
TRPV3 gain-of-function mutations have been identified in patients with Olmsted syndrome, which is associated with severe pruritus. However, the mechanisms causing itch remain poorly understood. Here, we show that keratinocytes lacking TRPV3 impair the function of pr …
TRPV3 gain-of-function mutations have been identified in patients with Olmsted syndrome, which is associated with severe pruri …
Cardiometabolic Health and Longitudinal Progression of White Matter Hyperintensity: The Mayo Clinic Study of Aging.
Scharf EL, Graff-Radford J, Przybelski SA, Lesnick TG, Mielke MM, Knopman DS, Preboske GM, Schwarz CG, Senjem ML, Gunter JL, Machulda M, Kantarci K, Petersen RC, Jack CR Jr, Vemuri P. Scharf EL, et al. Stroke. 2019 Nov;50(11):3037-3044. doi: 10.1161/STROKEAHA.119.025822. Epub 2019 Sep 12. Stroke. 2019. PMID: 31510903 Free PMC article. Clinical Trial.
Methods- This cohort study included participants enrolled in the Mayo Clinic Study of Aging, a longitudinal population-based study in Olmsted County, Minnesota with at least 2 consecutive WMH assessments on fluid-attenuated inversion recovery-magnetic resonance imag …
Methods- This cohort study included participants enrolled in the Mayo Clinic Study of Aging, a longitudinal population-based study in Olm …
Seroprevalence and durability of rubella virus antibodies in a highly immunized population.
Crooke SN, Haralambieva IH, Grill DE, Ovsyannikova IG, Kennedy RB, Poland GA. Crooke SN, et al. Vaccine. 2019 Jun 27;37(29):3876-3882. doi: 10.1016/j.vaccine.2019.05.049. Epub 2019 May 21. Vaccine. 2019. PMID: 31126859 Free PMC article.
The maintenance of herd immunity against rubella virus (RV) is important to controlling the spread and resurgence of rubella and congenital rubella syndrome. METHODS: In this study, we sought to assess the seroprevalence of RV-specific antibodies in an adult population fro …
The maintenance of herd immunity against rubella virus (RV) is important to controlling the spread and resurgence of rubella and congenital …
67 results